Revolution Medicines (RVMD) Return on Capital Employed [ROCE] (2020 - 2026)
Revolution Medicines' Return on Capital Employed [ROCE] came in at -55.45% for Q2 2026, down 14.90 percentage points from -40.56% a year earlier but up 13.39 percentage points from the prior quarter.
Powered by 
Analysis
Revolution Medicines (RVMD) Return on Capital Employed [ROCE] (2020 - 2026) Analysis & Trends
For FY2025, Revolution Medicines' Return on Capital Employed [ROCE] was -54.59%, down 22.46 percentage points from FY2024.
- Return on Capital Employed [ROCE] carries a five-year change of -22.67 percentage points (FY2020 to FY2025).
- Going back by year, Return on Capital Employed [ROCE] was -32.13% in FY2024 (+5.55 pp), -37.68% in FY2023 (-1.45 pp), -36.23% in FY2022 (-4.49 pp) and -31.74% in FY2021 (+0.18 pp).
- The five-year range for quarterly Return on Capital Employed [ROCE] is -68.84% (Q1 2026) to -24.08% (Q3 2021).
- Year-over-year, Return on Capital Employed [ROCE] has declined for six consecutive quarters, with an average year-over-year change of -11.83 percentage points over the last eight quarters.
- The fastest year-over-year change in Return on Capital Employed [ROCE] over five years came in Q2 2023 (a gain of 5.68 percentage points), and the weakest in Q1 2026 (a drop of 34.57 percentage points).
- Business Quant data shows RVMD's Return on Capital Employed [ROCE] at -68.84% (Q1 2026), -58.74% (Q4 2025) and -49.50% (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,122.91 Bn | 1,091.50 Bn | 19.71 Bn | 46.74% |
| 2 | Johnson & Johnson | 615.09 Bn | 533.62 Bn | 17.26 Bn | 17.83% |
| 3 | AbbVie | 504.75 Bn | 477.86 Bn | 12.70 Bn | 17.92% |
| 4 | Merck | 360.18 Bn | 314.55 Bn | 12.21 Bn | 6.28% |
| 5 | Novartis Ag | 292.05 Bn | 256.04 Bn | 11.24 Bn | 19.32% |
| 6 | Astrazeneca | 256.09 Bn | 229.78 Bn | 12.86 Bn | 16.76% |
| 7 | Amgen | 233.63 Bn | 189.02 Bn | 7.24 Bn | 16.66% |
| 8 | Gilead Sciences | 194.49 Bn | 168.69 Bn | 6.22 Bn | -5.97% |
| 9 | Pfizer | 168.35 Bn | 114.99 Bn | 10.94 Bn | 11.86% |
| 10 | Revolution Medicines | 37.70 Bn | 27.90 Bn | - | -55.45% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -55.45% |
| Mar 31, 2026 | -68.84% |
| Dec 31, 2025 | -58.74% |
| Sep 30, 2025 | -49.50% |
| Jun 30, 2025 | -40.56% |
| Mar 31, 2025 | -34.27% |
| Dec 31, 2024 | -34.53% |
| Sep 30, 2024 | -39.00% |
| Jun 30, 2024 | -34.27% |
| Mar 31, 2024 | -29.23% |
| Dec 31, 2023 | -35.33% |
| Sep 30, 2023 | -39.10% |
| Jun 30, 2023 | -32.37% |
| Mar 31, 2023 | -31.02% |
| Dec 31, 2022 | -34.12% |
| Sep 30, 2022 | -38.03% |
| Jun 30, 2022 | -38.05% |
| Mar 31, 2022 | -31.94% |
| Dec 31, 2021 | -27.81% |
| Sep 30, 2021 | -24.08% |
API Access
Revolution Medicines Return on Capital Employed [ROCE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=RVMD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-capital-employed-[roce]", "ticker": "RVMD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=RVMD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();